The global Duchenne Muscular Dystrophy (DMD) Therapeutics market size was estimated at USD 1329.20 million in 2024 and is projected to reach USD 31400.53 million by 2032, exhibiting a CAGR of 42.10% during the forecast period.
North America Duchenne Muscular Dystrophy (DMD) Therapeutics market size was estimated at USD 641.42 million in 2024, at a CAGR of 36.09% during the forecast...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek